Related Experiment Video
Updated: May 11, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Renal insufficiency in IBD--prevalence and possible pathogenetic aspects
Christian Primas1, Gottfried Novacek, Karin Schweiger
1Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Austria.
Renal insufficiency (RI) affects nearly 2% of Crohn's disease patients, often linked to extensive bowel resection and kidney stones. Ulcerative colitis patients showed no signs of RI.
Area of Science:
- Gastroenterology
- Nephrology
- Internal Medicine
Background:
- Extraintestinal manifestations in Inflammatory Bowel Disease (IBD) are often overlooked, particularly those affecting parenchymatous organs like the kidneys.
- Renal insufficiency (RI) is a potential, yet rarely recognized, complication in IBD patients.
Purpose of the Study:
- To determine the prevalence of renal insufficiency (RI) in patients with Inflammatory Bowel Disease (IBD).
- To identify potential causative factors and pathogenetic aspects associated with RI in IBD.
Main Methods:
- A two-part study design was employed.
- Part one assessed RI prevalence in 775 IBD patients from March 2006 to December 2007.
- Part two compared 25 IBD patients with RI against 50 IBD patients without RI, analyzing gastroenterologic and renal parameters.
Main Results:
- RI was identified in 11 out of 775 IBD patients (1.99%), exclusively among those with Crohn's disease (CD).
- No cases of RI were observed in patients with ulcerative colitis (UC).
- Significant risk factors for RI included longer disease duration, extensive small bowel resection, recurrent urolithiasis, and multiple kidney stone interventions.
Conclusions:
- Renal insufficiency is a rare but significant complication in Crohn's disease, with a prevalence of approximately 2%.
- Ulcerative colitis does not appear to be associated with RI in this study.
- Extensive small bowel resection and recurrent urolithiasis are identified as primary causative factors for RI in CD patients.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations